/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

Z

Zhongying Mo

Bristol-Myers Squibb (Germany)(DE)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

19

Papers

647

Citations

8

h-index

8

i10-index

Zhongying Mo is an academic researcher from Bristol-Myers Squibb (Germany). The author has contributed to research in topics: RNA modifications and cancer & Protein Degradation and Inhibitors & RNA and protein synthesis mechanisms. The author has an h-index of 8, co-authored 17 publications.

ORCID: 0009-0006-3459-1365

Research Topics

RNA modifications and cancer Protein Degradation and Inhibitors RNA and protein synthesis mechanisms Ubiquitin and proteasome pathways Lymphoma Diagnosis and Treatment

Papers by this author

works

Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot-Marie-Tooth neuropathy

2018 · Nature Communications · 114 citations

https://doi.org/10.1038/s41467-018-03461-z

Zhongying Mo Xiaobei Zhao Huaqing Liu Qinghua Hu

Resveratrol attenuates the CoCl2-induced hypoxia damage by regulation of lysine β-hydroxybutyrylation in PC12 cells

2025 · BMC Neurology · 2 citations

https://doi.org/10.1186/s12883-025-04171-y

Yamei Wang Jian Zhao Liang Sun Dan Xu

Research topics

topics

RNA modifications and cancer

Protein Degradation and Inhibitors

RNA and protein synthesis mechanisms

Ubiquitin and proteasome pathways

Lymphoma Diagnosis and Treatment

Chat about Author

Papers

Chat

Click to start Chat